Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Ann Vasc Surg ; 28(2): 494.e9-14, 2014 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-24332897

RESUMEN

We report a case of a staged surgical and endovascular management in a 62-year-old woman with aortic coarctation associated with aortic valve stenosis and mitral regurgitation. The patient was admitted for severe aortic valve stenosis and mitral valve incompetence. During hospitalization and preoperative imaging, a previously undiagnosed aortic coarctation was discovered. The patient underwent a 2-stage approach that combined a Bentall procedure and mitral valve replacement in the first stage, followed by correction of the aortic coarctation by percutaneous placement of an Advanta V12 large-diameter stent graft (Atrium, Mijdrecht, The Netherlands) which to our knowledge has not been used in an adult patient with this combination of additional cardiac comorbidities. A staged approach combining surgical treatment first and endovascular placement of an Advanta V12 stent graft in the second stage can be effective and safe in adult patients with coarctation of the aorta and additional cardiac comorbidities.


Asunto(s)
Coartación Aórtica/cirugía , Estenosis de la Válvula Aórtica/cirugía , Implantación de Prótesis Vascular/instrumentación , Prótesis Vascular , Procedimientos Endovasculares/instrumentación , Implantación de Prótesis de Válvulas Cardíacas , Insuficiencia de la Válvula Mitral/cirugía , Stents , Angiografía de Substracción Digital , Coartación Aórtica/complicaciones , Coartación Aórtica/diagnóstico , Estenosis de la Válvula Aórtica/diagnóstico , Estenosis de la Válvula Aórtica/etiología , Aortografía/métodos , Femenino , Humanos , Persona de Mediana Edad , Insuficiencia de la Válvula Mitral/diagnóstico , Insuficiencia de la Válvula Mitral/etiología , Tomografía Computarizada Multidetector , Diseño de Prótesis , Índice de Severidad de la Enfermedad , Resultado del Tratamiento
2.
Lijec Vjesn ; 132 Suppl 1: 32-5, 2010.
Artículo en Croata | MEDLINE | ID: mdl-20715719

RESUMEN

In order to simplify and to standardize procedures during cardiac arrest in patients after cardiac surgery and for professional medical staff education, working group of the European Association for Cardio-Thoracic Surgery issued in 2009 "Guideline for resuscitation in cardiac arest after cardiac surgery". There are several differences between these guidelines and guidelines for general population: in ventricular fibrillation, three sequential attempts at defibrillation should precede external cardiac massage; in asystole or extreme bradycardia, pacing should precede external cardiac massage. Where the above measures fail, and in pulseless electrical activity, early resternotomy is advocated. Adrenaline should not be routinely given. Also protocols for excluding reversible airway and breathing complications and for safe emergency resternotomy are given. These guidelines in very simple and professional way define rules for resuscitation of patients after cardiac surgery. It is a useful manual which will certainly find its place in daily work of professional medical staff involved in healthcare of these patients.


Asunto(s)
Procedimientos Quirúrgicos Cardíacos , Cuidados Críticos , Paro Cardíaco/terapia , Hemodinámica , Monitoreo Fisiológico , Resucitación , Humanos
3.
Coll Antropol ; 34 Suppl 1: 307-9, 2010 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-20402339

RESUMEN

Interrupted aortic arch (IAA) is a congenital defect characterized by loss of luminal continuity between the ascending and descending aorta1. It is a rare malformation with an estimated incidence of perinatally diagnosed cases of 3 per million live births3. The condition is considered extremely rare in adults. However, its true prevalence in this population is unknown. We have found 30 case reports of IAA in adults in literature, 5 of whom were older than 50 years. Four of them had type A IAA. Arterial hypertension is a typical co-morbidity. In this report we describe a 60-year-old male patient who had a type A asymptomatic IAA. Although we initially suspected the aortic coarctation, further invasive procedures revealed complete interruption of the aortic arch just distal to the origin of the left subclavian artery. The patient underwent surgical repair, followed by full recovery and near-normalization of blood pressure.


Asunto(s)
Aorta Torácica/anomalías , Hipertensión/etiología , Estudios de Seguimiento , Humanos , Masculino , Persona de Mediana Edad
4.
Regul Pept ; 156(1-3): 83-9, 2009 Aug 07.
Artículo en Inglés | MEDLINE | ID: mdl-19465062

RESUMEN

Pentadecapeptide BPC 157 (GEPPPGKPADDAGLV, MW 1419) reversed congestive heart failure and various arrhythmias, influenced the NO-system and showed no proarrhythmic effect. In therapy analogy, we challenged rats with digitalis, to show attenuation by BPC 157 and the relation between the NO-system and digitalis toxicity. (i). BPC 157 prophylactic effect. Development of cumulative intravenous digitalis toxicity, BPC 157 (50 microg, 10 microg, 10 ng/kg applied intravenously immediately before a methyldigoxin increment regimen (2.0/1.5/1.5/1.0 mg/kg at 15 min-intervals, total dose 6.0 mg/kg/45 min)) reduced the number of ventricular premature beats, prolonged the time before onset of ventricular tachycardia, reduced ventricular tachycardia and AV-block duration (microg-regimes) or reduced mainly the AV-block duration (ng-regimen). (ii). BPC 157 therapy. Advanced methyldigoxin toxicity (6.0 mg/kg i.v. bolus). BPC 157 applied at the 20th second of the grade 3 AV-block shortened AV-blocks, mitigated a further digitalis toxicity course. Ventricular tachycardias were either avoided (50 microg), or markedly reduced (10 microg, 10 ng). Fatal outcome was either avoided (50 microg), reduced (10 microg), or only delayed (10 ng) (iii) BPC 157, L-NAME, l-arginine, L-NAME+l-arginine application. L-NAME-application (5 mg/kg i.p.) aggravated methyldigoxin-arrhythmias. l-arginine (200 mg/kg i.p.) alone had no effect but blunted L-NAME-exaggeration (L-NAME+l-arginine). In this respect, BPC 157 (50 microg/kg i.p.) was prophylactically and therapeutically more effective: the antagonism of L-NAME with BPC 157 produced an effect similar to BPC 157 alone. In conclusion, digitalis-induced arrhythmias in rats could be prevented and counteracted by pentadecapeptide BPC 157, mainly through an interaction with the NO-system.


Asunto(s)
Antiarrítmicos/farmacología , Arritmias Cardíacas/inducido químicamente , Frecuencia Cardíaca/efectos de los fármacos , Medigoxina/farmacología , Óxido Nítrico/metabolismo , Fragmentos de Péptidos/farmacología , Proteínas/farmacología , Animales , Antiulcerosos/farmacología , Arginina/farmacología , Arritmias Cardíacas/tratamiento farmacológico , Arritmias Cardíacas/prevención & control , Masculino , NG-Nitroarginina Metil Éster/farmacología , Ratas , Ratas Wistar
5.
Eur J Cardiothorac Surg ; 32(6): 882-7, 2007 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-17904857

RESUMEN

OBJECTIVE: The etiology of lung injury following cardiopulmonary bypass (CPB) is multifactorial. Our study focused on quantifying the lactate release from the lungs precipitated by extracorporeal circulation at different time points after the insult. This was complemented by an evaluation of the gas exchange at the level of the alveolar-capillary membrane. METHODS: Forty consecutive patients (age 61+/-11 years, EuroScore 4.7+/-2.7) undergoing CABG were prospectively analyzed. The data are presented as medians and the interquartile range. RESULTS: The pulmonary lactate release (PLR) increased from a baseline value of 0.033 (range -0.077 to 0.170) to 0.465 mmol/min/m2 (range 0.113-0.922), which was seen 6h postoperatively (P<0.001). The A-a O2 gradient increased from 12.7 (range 8.8-15) to 39.1 kPa (range 30.3-46.5) upon discontinuation of CPB (P<0.001). The systemic arterial lactate (LS) concentration increased from 1.22 (range 1-1.44) to 3.03 mmol/l (range 2.29-4.76) 6h after surgery (P<0.001). The veno-arterial pCO2 difference (V-A dpCO2) rose from 0.6 (range 0.5-0.9) to 0.9 kPa (range 0.7-1) (P=0.014). The mortality in the studied group was 5% (2/40). CONCLUSIONS: The lungs were found to be a significant source of lactate, and this pulmonary lactate flux was accentuated by CPB. The PLR correlated with systemic hyperlactatemia as well as the A-a O2 gradient, and was found to be higher in patients requiring prolonged mechanical ventilatory support. The duration of CPB had a significant impact on the systemic lactate concentrations, V-A dpCO2 and the A-a O2 gradient, but not on the PLR.


Asunto(s)
Puente Cardiopulmonar , Puente de Arteria Coronaria , Ácido Láctico/metabolismo , Pulmón/metabolismo , Anciano , Dióxido de Carbono/sangre , Femenino , Humanos , Ácido Láctico/sangre , Masculino , Persona de Mediana Edad , Oxígeno/sangre , Presión Parcial , Periodo Posoperatorio , Estudios Prospectivos , Intercambio Gaseoso Pulmonar , Respiración Artificial
6.
Ann Thorac Surg ; 82(5): 1891-2, 2006 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-17062269

RESUMEN

Cardiac fibromas are exceedingly rare neoplasms. We report the case of a 21-year-old woman who presented with symptoms that were initially misinterpreted as an acute coronary syndrome. Radical surgical resection was undertaken and was considered curative, as the mass histology was consistent with a benign fibroma.


Asunto(s)
Fibroma/diagnóstico , Neoplasias Cardíacas/diagnóstico , Adulto , Diagnóstico Diferencial , Ecocardiografía , Electrocardiografía , Femenino , Fibroma/cirugía , Neoplasias Cardíacas/cirugía , Ventrículos Cardíacos , Humanos , Isquemia Miocárdica/diagnóstico , Tomografía Computarizada por Rayos X
7.
Coll Antropol ; 30(4): 909-13, 2006 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-17243569

RESUMEN

The best option for the treatment of a failing heart is heart transplantation. The transplantation program at the University Hospital Center Rebro Zagreb started in 1988. To the best of our knowledge this is the first retrospective study on cardiac transplantation in Croatia looking into survival following heart transplantation. Between 1988 and 2006, we performed 81 heart transplantations at the University Hospital Center Rebro Zagreb. Our study focused on the last ten years after establishment of the Department of cardiac surgery as a separate institution. There were thirteen different hospitals throughout Croatia, which contributed to the donor network. Average age of the heart recipient was 48+/-11.8 years (range 14-72), and average age of the heart donor was 34+/-10.7 years (range 14-56). There were more women among the heart donors (34%) then among the heart recipients (18%). During the first ten years, from 1988-1998, the average number of cardiac transplantations was 3 per year In the period from 1998-2006, average number of cardiac transplantations increased to 6 per year. The average thirty-day mortality for the last nine years was 27%. It declined from 30% and 40% in 1998 and 1999, respectively down to 0% in the last two years. Average age of the patients who died was 50+/-6.5years (range 44-62) and did not significantly differ from those who survived. The donor network has grown up to fourteen different hospitals throughout Croatia. The limiting factor in cardiac transplant surgery is the number of available donors. Therefore in attempt to form a good transplant program it is crucial to form an efficient donor network. The number of performed cardiac transplantations is expected to rise until it reaches the number of available donors. With advances in operative technique and postoperative management--immunosuppressive therapy we have observed a remarkable drop in the early operative mortality in the studied period.


Asunto(s)
Trasplante de Corazón , Adolescente , Adulto , Anciano , Croacia/epidemiología , Femenino , Trasplante de Corazón/mortalidad , Trasplante de Corazón/estadística & datos numéricos , Humanos , Masculino , Persona de Mediana Edad , Tasa de Supervivencia
8.
Lijec Vjesn ; 124(10): 310-3, 2002 Oct.
Artículo en Croata | MEDLINE | ID: mdl-12619440

RESUMEN

The infection of a transvenous lead implanted for cardiac stimulation is a rare, but serious complication. We report observation of a 25-year old man whose Staphylococcus epidermidis sepsis linked to endocarditis was related to atrial and ventricular pacing leads, and was diagnosed after two months of medical treatment. The most important role during the diagnostic process was played by the echocardiographic examination, especially transoesophageal, which revealed the large vegetations on atrial as well as ventricular pacing lead. The diagnosed condition was treated by complete removal of pacing system using open chest surgery and cardiopulmonary pump. After four weeks of vigorous antibiotic treatment, a new DDDR pacing system was implanted, but with epicardial leads.


Asunto(s)
Endocarditis/etiología , Marcapaso Artificial/efectos adversos , Infecciones Estafilocócicas/etiología , Staphylococcus epidermidis , Adulto , Endocarditis/diagnóstico por imagen , Humanos , Infecciones Estafilocócicas/diagnóstico , Ultrasonografía
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...